Sagimet Biosciences (SGMT) Current Leases (2022 - 2026)
Sagimet Biosciences' (SGMT) quarterly Current Leases came in at $39000.0 in Q1 2026, little changed year-on-year from $39000.0 in Q1 2025, and down 50.0% quarter-over-quarter from $78000.0 in Q4 2025.
Sagimet Biosciences (SGMT) Current Leases (2022 - 2026) Analysis & Trends
Sagimet Biosciences' Current Leases history runs 5 years deep, the most recent figure standing at $39000.0 for Q1 2026.
- On a quarterly basis, Current Leases changed 0.0% year-over-year to $39000.0 in Q1 2026; TTM through Mar 2026 was $39000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $78000.0, changed 0.0% from the prior year.
- Current Leases declined to $39000.0 in Q1 2026 per SGMT's latest filing, from $78000.0 in the prior quarter.
- Across five years, Current Leases topped out at $153000.0 in Q2 2024 and bottomed at $26000.0 in Q1 2024.
- The 5-year median for Current Leases is $103000.0 (2023), against an average of $95153.8.
- Across the five-year window, Current Leases slumped 51.13% in 2023 and soared 50.0% in 2025, its largest moves.
- Year by year, Current Leases stood at $133000.0 in 2022, then slumped by 51.13% to $65000.0 in 2023, then gained by 20.0% to $78000.0 in 2024, then changed by 0.0% to $78000.0 in 2025, then sank by 50.0% to $39000.0 in 2026.
- Per Business Quant, the three latest SGMT Current Leases figures stand at $39000.0 (Q1 2026), $78000.0 (Q4 2025), and $115000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Sagimet Biosciences | 228.24 Mn | 228.24 Mn | - | 39,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39,000.00 |
| Dec 31, 2025 | 78,000.00 |
| Sep 30, 2025 | 115,000.00 |
| Jun 30, 2025 | 152,000.00 |
| Mar 31, 2025 | 39,000.00 |
| Dec 31, 2024 | 78,000.00 |
| Sep 30, 2024 | 116,000.00 |
| Jun 30, 2024 | 153,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Dec 31, 2023 | 65,000.00 |
| Sep 30, 2023 | 103,000.00 |
| Jun 30, 2023 | 140,000.00 |
| Dec 31, 2022 | 133,000.00 |